Magazine | IBA | Protect Enhance and Save lives

Improve the environmental sustainability of cancer care

How can we improve the environmental impact of cancer care in the growing context of climate change and worldwide ecological issues?

First proton therapy system restoration at Massachusetts General Hospital

The journey of proton therapy for cancer treatment has been transformative, particularly at Massachusetts General Hospital (MGH). The discussion led by Dr. Helen Shih and Dr. Anthony Zietman highlights the advancements in proton therapy at MGH since its initial installation in the 1960s, and the excitement of the first restoration of a proton therapy system. Dr. Shih is the medical director of the Proton Therapy Center, specializing in brain and ocular tumors, while Dr. Zietman, former chief of Radiation Oncology, specializes in genitourinary (GU) oncology and has been using proton therapy since for almost four decades.

The Strategic and Clinical Benefits of Compact Proton Therapy at TMUH

In the heart of Taipei, where every square meter is precious and the demand for advanced healthcare is ever-growing, Taipei Medical University Hospital (TMUH) redefined its approach to cancer care by integrating proton therapy as a core component of its world-class oncology program. At the core of this transformation is ProteusONE, IBA’s compact proton therapy system, selected for its ability to address the unique challenges of urban hospital environments while meeting TMUH’s clinical needs for precision and efficiency.

In this article, we dive into the expert testimonials of five TMUH leaders whose roles span the entire proton therapy ecosystem: from institutional leadership to hands-on patient care. Their combined insights reveal how ProteusONE has overcome spatial and operational constraints, redefined clinical efficiency, enhanced the patient experience, and strengthened TMUH’s institutional strategy in one of Asia’s most densely populated cities.

The role of proton beam quality in cancer treatment

In proton therapy, the design of the system significantly influences key beam parameters, and can have a direct impact on patient care. Thus, it is important to understand beam quality's role in radiotherapy and cancer treatment.

Benefits of adding proton therapy with ProteusONE

Proton therapy represents a significant advancement in radiation oncology. In this article, Dr. Craig Stevens, Chair of Radiation Oncology at Corewell Health’s William Beaumont University Hospital Proton Therapy Center, discusses the evolution and benefits of their ProteusONE system installed in 2017.

Boosting patient care and institutional growth with Proton Therapy

The University of Kansas Cancer Center has significantly enhanced patient care and institutional growth by integrating proton therapy into their treatment options. As a National Cancer Institute (NCI) designated Comprehensive Cancer Center, they recognized the need for advanced particle beam treatments for the diverse patient population they serve, particularly for their pediatric cancer patients. Darin Kistler, Senior Director of Radiation Services, describes the center's evolution since installing the ProteusONE proton therapy system in 2017.

Cookies policy

Manage your cookie preferences